Models versus pathogens: how conserved is the FtsZ in bacteria?
Bioscience Reports · 27.02.2023 · 43 (2)
DOI: 10.1042/bsr20221664 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, online erschienen am 10.02.2023. Verfasst von Rachana Rao Battaje und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai 400076, India. Hauptthemen laut MEDLINE: Cytoskeletal Proteins, Escherichia coli. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Combating anti-microbial resistance by developing alternative strategies is the need of the hour. Cell division, particularly FtsZ, is being extensively studied for its potential as an alternative target for anti-bacterial therapy. Bacillus subtilis and Escherichia coli are the two well-studied models for research on FtsZ, the leader protein of the cell division machinery. As representatives of gram-positive and gram-negative bacteria, respectively, these organisms have provided an extensive outlook into the process of cell division in rod-shaped bacteria. However, research on other shapes of bacteria, like cocci and ovococci, lags behind that of model rods. Even though most regions of FtsZ show sequence and structural conservation throughout bacteria, the differences in FtsZ functioning and interacting partners establish several different modes of division in different bacteria. In this review, we compare the features of FtsZ and cell division in the model rods B. subtilis and E. coli and the four pathogens: Staphylococcus aureus, Streptococcus pneumoniae, Mycobacterium tuberculosis, and Pseudomonas aeruginosa. Reviewing several recent articles on these pathogenic bacteria, we have highlighted the functioning of FtsZ, the unique roles of FtsZ-associated proteins, and the cell division processes in them. Further, we provide a detailed look at the anti-FtsZ compounds discovered and their target bacteria, emphasizing the need for elucidation of the anti-FtsZ mechanism of action in different bacteria. Current challenges and opportunities in the ongoing journey of identifying potent anti-FtsZ drugs have also been described.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai 400076, India.
- National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab 160062, India.
ORCID-Profile: Dulal Panda
Zitieren
APA
Battaje, R. R., Piyush, R., Pratap, V., & Panda, D. (2023). Models versus pathogens: how conserved is the FtsZ in bacteria?. Bioscience Reports, 43(2). https://doi.org/10.1042/bsr20221664
Vancouver
Battaje RR, Piyush R, Pratap V, Panda D. Models versus pathogens: how conserved is the FtsZ in bacteria?. Bioscience Reports. 2023;43(2). doi:10.1042/bsr20221664
BibTeX
@article{Battaje2023,
author = {Battaje, Rachana Rao and Piyush, Ravikant and Pratap, Vidyadhar and Panda, Dulal},
title = {Models versus pathogens: how conserved is the FtsZ in bacteria?},
journal = {Bioscience Reports},
year = {2023},
volume = {43},
number = {2},
doi = {10.1042/bsr20221664}
}
EUVIMED